Publication | Closed Access

Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression

Cdk4 ExpressionBreast OncologyCyclin D1MedicinePharmacologyBreast CancerCyclin D1/cdk4Tumor SuppressorCancer TreatmentAnti-cancer AgentOncologyCell BiologyTumor Biology